Skip to Content

Tag: Financial Results


Resmed targets ‘strong execution’ in marketing

Vendors

Resmed targets ‘strong execution’ in marketing

October 30, 2026Liz Beaulieu, Editor

SAN DIEGO – Resmed is betting that a growing slate of consumer marketing programs and partnerships will help it reach the high end of its 5% to 7% core constant currency revenue growth target for fiscal year 2027. The initiatives did not contribute materially to first-quarter results, but CEO Mick Farrell says efforts to raise awareness of sleep apnea and encourage patients to seek treatment can help drive longer-term growth. “(CFO Aaron Bloomer) talked about what would get us to...

consumer marketing, Financial Results, First Quarter (Q1), fiscal year 2027, ResMed


Read Full Articlered right arrow icon

Casey Hoyt

Specialty Providers

Viemed’s growth engine gains momentum

August 21, 2026Theresa Flaherty

LAFAYETTE, La. – Viemed posted new highs in the second quarter with growth across its core ventilation business and continued expansion in its sleep resupply and maternal health lines, say company execs. “At the midpoint of the year, Viemed is larger and more diversified than ever,” said CEO Casy Hoyt on a recent call to discuss the company’s earnings. “We entered the second half with multiple sources of growth, a larger patient base and the financial capacity to...

2026, Financial Results, maternal health, Resupply, Second Quarter (Q2), ventilation, Viemed Healthcare


Read Full Articlered right arrow icon

Perry Bernocchi

Providers

Accendra Health ready to put weak Q2 in rear view

August 14, 2026Theresa Flaherty

RICHMOND, Va. – Accendra Health’s second quarter results “did not meet expectations,” thanks to lower revenue growth and other challenges, but executives pointed to several growth opportunities in upcoming quarters and overall improvement in its sleep business as evidence of the company’s strength. For the quarter, the company saw lower revenue growth, slower than-expected collection recovery and a delay in cost reduction initiatives, said Edward Pesicka, president...

2026, Accendra Health, CPAP Therapy, Financial Results, Second Quarter (Q2)


Read Full Articlered right arrow icon

Michael Drazian

Vendors

Medline cites fire costs, growth investments as part of moderated outlook

August 14, 2026Liz Beaulieu, Editor

NORTHFIELD, Ill. – Medline’s first-half financial results included $336 million in costs related to the June fire that destroyed one of its distribution centers in Tracy, Calif. The company expects to incur another $50 million to $100 million in fire-related costs during the second half of the year. CEO Jim Boyle said expenses such as cleanup, product rerouting and airfreight will be excluded from Medline’s adjusted EBITDA, while other costs, including lease expenses and labor...

2026, Financial Results, first half, Medline, Tracy fire


Read Full Articlered right arrow icon

Vendors

Cardinal Health calls FY2026 ‘a standout year’

August 11, 2026HME News Staff

DUBLIN, Ohio – Cardinal Health has reported fourth quarter fiscal year 2026 revenues of $63.7 billion, a 6% increase from the prior-year quarter. GAAP operating earnings increased 70% to $729 million and GAAP diluted earnings per share increased 70% to $1.70. The company re GAAP operating earnings were $2.6 billion and GAAP diluted EPS was $7.23. “Fiscal 2026 was a standout year for Cardinal Health and I am pleased with our strong fourth quarter results,” said Jason Hollar,...

Cardinal Health, Financial Results, fiscal year 2026, fourth quarter


Read Full Articlered right arrow icon

Edward Pesicka

Providers

Accendra Health: Expansion opportunities will emerge later in 2026, accelerate in 2027

August 10, 2026HME News Staff

RICHMOND, Va. – Accendra Health reported net revenue of $613.2 million for the second quarter of 2026 vs. $681.9 million for same period last year. Other financial results: Loss from continuing operations, net of tax, GAAP: ($89.1 million) vs. ($83.8 million) Adjusted (loss) income from continuing operations, net of tax, non-GAAP: ($14.3 million) vs. $20.5 million Adjusted EBITDA, non-GAAP: $60.1 million vs. $96.6 million Free cash flow, non-GAAP: ($25.1 million) vs. $15.2 million Loss...

2026, Accendra Health, Financial Results, Second Quarter (Q2)


Read Full Articlered right arrow icon

Suzanne Foster

Providers

AdaptHealth cites supplier, contract challenges in second-half outlook

August 7, 2026Liz Beaulieu, Editor

CONSHOHOCKEN, Pa. – AdaptHealth's disclosure that an unexpected manufacturer price increase will have a $30 million impact in the second half became a focal point for analysts during the company's second-quarter earnings call. CEO Suzanne Foster said a manufacturer notified AdaptHealth on June 30 that it was terminating its contract with the company and implementing an immediate price increase effective July 1. “We are actively working with the manufacturer to secure improved...

2026, AdaptHealth, Capitated Contracts, Financial Results, manufacturer price increase, Second Quarter (Q2)


Read Full Articlered right arrow icon

McKesson signals next phase for MMS with new name

Vendors

McKesson signals next phase for MMS with new name

August 7, 2026Liz Beaulieu, Editor

IRVING, Texas – McKesson’s Medical-Surgical Solutions business plans to formally operate as Wellverse starting in January 2027, as part of a phased transition, says McKesson CEO Brian Tyler. The company announced the new name on Aug. 5 as part of its financial results for the first quarter of fiscal year 2027. “Wellverse delivers a future where health care providers and patients thrive,” Tyler said during a conference call to discuss the results. “This is an important...

Financial Results, First Quarter (Q1), fiscal year 2027, McKesson, McKesson Medical-Surgical, Wellverse


Read Full Articlered right arrow icon

Kevin Smith

Vendors

Channel shift continues to boost B2B, pressure DTC at Inogen

August 7, 2026Liz Beaulieu, Editor

BEVERLY, Mass. – Inogen expects its U.S. business to return to overall growth in the second half of 2026, driven by momentum in its business-to-business channel as it works through continued pressure in its direct-to-consumer and rental channels. Inogen reported U.S. sales were $42.3 million in the second quarter, as the strong mid-single-digit revenue growth in its B2B channel was not enough to offset channel mix challenges. “Results in DTC reflect a market shift where HMEs are...

2026, Financial Results, Inogen, Portable Oxygen Concentrator (POC), Second Quarter (Q2)


Read Full Articlered right arrow icon

Vendors

Resmed reports double-digit increase in revenue for full year 2026

August 6, 2026HME News Staff

SAN DIEGO – Resmed reported revenue of $1.5 billion for the fourth quarter of fiscal year 2026, a 9% increase, and $5.7 billion for the full year, a 10% increase. “We closed fiscal year 2026 with strong fourth quarter results, reflecting continued momentum of our global business, sustained demand for our market-leading products, and disciplined execution of our strategy,” said Chairman and CEO Mick Farrell. “Year-over-year, we delivered 9% reported revenue growth, 90 basis...

2026, Financial Results, fourth quarter, full year, ResMed


Read Full Articlered right arrow icon